Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:
USARx offers the following ways to purchase this medication. Choose the Best option for you!
Clofarabine is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Clofarabine is used to treat acute lymphoblastic leukemia (a type of blood cancer) in children and young adults up to 21 years old.
Clofarabine is usually given after other cancer medicines have been tried without successful treatment.
Clofarabine may also be used for purposes not listed in this medication guide.
clofarabine can cause life-threatening side effects including: serious infection, severe skin rash, internal bleeding, and liver or kidney damage.
Call your doctor right away if you have: fever, chills, unusual bleeding or bruising, urination problems, stomach pain or swelling, loss of appetite, bloody diarrhea, coughing up blood, sudden numbness or severe headache, problems with vision or balance, or sudden swelling in your arms, legs and other parts of the body.
To make sure clofarabine is safe for you, tell your doctor if you have:
any type of infection;
liver disease; or
kidney disease.
Using clofarabine during pregnancy could harm the unborn baby. Tell your doctor if you are pregnant or if you become pregnant while using this medicine.
Use birth control to prevent pregnancy while you are receiving clofarabine, whether you are a man or a woman. Clofarabine use by either parent may cause birth defects.
It is not known whether clofarabine passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are receiving clofarabine.
Clofarabine is injected into a vein through an IV. A healthcare provider will give you this injection.
Clofarabine is usually given daily for 5 days in a row during one or more 1-month treatment cycles. Your doctor will determine how many treatment cycles you will receive and how often.
You may receive other medications to help prevent certain side effects of clofarabine.
Clofarabine can lower blood cells that help your body fight infections and help your blood to clot. Your blood will need to be tested often. Your kidney or liver function may also need to be tested. Your cancer treatments may be delayed based on the results of these tests.
Call your doctor for instructions if you miss an appointment for your clofarabine injection.
Since clofarabine is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.
Avoid being near people who are sick or have infections. Tell your doctor at once if you develop signs of infection.
clofarabine can pass into body fluids (urine, feces, vomit). For at least 48 hours after you receive a dose, avoid allowing your body fluids to come into contact with your hands or other surfaces. Caregivers should wear rubber gloves while cleaning up a patient's body fluids, handling contaminated trash or laundry or changing diapers. Wash hands before and after removing gloves. Wash soiled clothing and linens separately from other laundry.
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
A rare but serious side effect of clofarabine is called capillary leak syndrome. Call your doctor right away if you have signs of this condition, which may include: stuffy or runny nose followed by weakness or tired feeling, and sudden swelling in your arms, legs and other parts of the body.
Call your doctor at once if you have:
severe stomach pain, diarrhea that is watery or bloody;
a light-headed feeling, like you might pass out;
pain, redness, numbness, and peeling skin on the palms of your hands or the soles of your feet;
signs of infection--fever, chills, cold or flu symptoms, unusual weakness, mouth and throat ulcers, swollen gums, pain when swallowing, pale skin, easy bruising or bleeding (nosebleeds, bleeding gums), skin sores, rapid and shallow breathing, fainting;
signs of bleeding inside the body--sudden severe headache, chest pain, coughing up blood or vomit that looks like coffee grounds, rectal bleeding, bloody or tarry stools, sudden numbness or weakness (especially on one side of the body), problems with vision or speech;
signs of a liver problem--upper stomach pain, sudden swelling in your mid-section, jaundice (yellowing of the skin or eyes);
kidney problems--little or no urination, red or pink urine, painful or difficult urination, swelling in your feet or ankles, feeling tired or short of breath;
severe skin reaction--fever, sore throat, swelling in your face or tongue, burning in your eyes, skin pain, followed by a red or purple skin rash that spreads (especially in the face or upper body) and causes blistering and peeling; or
signs of tumor cell breakdown--lower back pain, blood in your urine, little or no urinating; numbness or tingly feeling around your mouth; muscle weakness or tightness; fast or slow heart rate, weak pulse, feeling short of breath; confusion.
Common side effects may include:
fever, chills, flu symptoms, or other signs of infection;
stomach pain, nausea, vomiting, loss of appetite, diarrhea;
fast heartbeats;
nosebleeds, bruising;
pain in your arms or legs;
headache, feeling tired or anxious;
mild itching or skin rash; or
flushing (warmth, redness, or tingly feeling).
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Usual Adult Dose for Acute Lymphoblastic Leukemia:
18 to less than 22 years:
52 mg/m2 IV over 2 hours daily for 5 consecutive days of a 28-day cycle; repeat every 2 to 6 weeks
Comments:
-Subsequent cycles should begin no sooner than 14 days from day 1 of the previous cycle.
-Subsequent cycles may be administered when the ANC is greater than or equal to 750/mm3.
-Provide supportive care, such as IV fluids, antihyperuricemics, and alkalinization of urine throughout therapy to reduce the risk of tumor lysis and other adverse events.
-Monitor renal, hepatic, and cardiac function during therapy.
-Monitor patients taking medications known to affect blood pressure.
-Discontinue therapy if hypotension develops during the 5 days of administration.
Use: For patients 1 to 21 years old with relapsed or refractory acute lymphoblastic leukemia after at least 2 prior regimens
Usual Pediatric Dose for Acute Lymphoblastic Leukemia:
1 year and older:
52 mg/m2 IV over 2 hours daily for 5 consecutive days of a 28-day cycle; repeat every 2 to 6 weeks
Comments:
-Subsequent cycles should begin no sooner than 14 days from day 1 of the previous cycle.
-Subsequent cycles may be administered when the ANC is greater than or equal to 750/mm3.
-Provide supportive care, such as IV fluids, antihyperuricemics, and alkalinization of urine throughout therapy to reduce the risk of tumor lysis and other adverse events.
-Monitor renal, hepatic, and cardiac function during therapy.
-Monitor patients taking medications known to affect blood pressure.
-Discontinue therapy if hypotension develops during the 5 days of administration.
Use: For patients 1 to 21 years old with relapsed or refractory acute lymphoblastic leukemia after at least 2 prior regimens
Tell your doctor about all medicines you use, and those you start or stop using during your treatment with clofarabine, especially blood pressure medication.
Clofarabine can harm your liver or kidneys. This effect is increased when you also use other medicines harmful to the liver or kidneys. During your 5-day treatment with clofarabine, you may need to avoid using certain medications. Many other drugs (including some over-the-counter medicines) can be harmful to the liver or kidneys, such as:
leflunomide, methotrexate, teriflunomide;
an antibiotic, antifungal medicine, antiviral medicine, sulfa drug, or tuberculosis medicine;
birth control pills or hormone replacement therapy;
gout or arthritis medications (including gold injections);
HIV/AIDS medications;
injectable osteoporosis medicine;
medication to prevent organ transplant rejection;
medicines to treat a bowel disorder;
medicines to treat mental illness;
other cancer medications;
cholesterol-lowering medications--Crestor, Lipitor, Pravachol, Simcor, Vytorin, Zocor, and others;
pain or arthritis medicines--acetaminophen (Tylenol), ibuprofen (Advil, Motrin), naproxen (Aleve), celecoxib, diclofenac, indomethacin, meloxicam, and others; or
seizure medication--carbamazepine, phenytoin, and others.
This list is not complete. Other drugs may interact with clofarabine, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.
Further informationRemember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Medically reviewed by USARx EDITORIAL TEAM Last updated on 1/27/2021.
Source: Drugs.com Clofarabine (www.drugs.com/mtm/clofarabine.html).
Commonly reported side effects of clofarabine include: febrile neutropenia, herpes simplex infection, infection, oral candidiasis, pericardial effusion, pleural effusion, pneumonia, respiratory distress, sepsis, staphylococcal infection, abdominal pain, anxiety, arthralgia, back pain, cellulitis, confusion, constipation, cough, depression, dermatitis, diarrhea, dizziness, drowsiness, dyspnea, edema, epistaxis, erythrodysesthesia syndrome, fatigue, fever, gingival hemorrhage, headache, hematuria, hepatomegaly, hypertension, hypotension, jaundice, lethargy, limb pain, mucositis, myalgia, nausea, neutropenia, pain, petechia, pruritus, rigors, sore throat, tachycardia, transfusion reaction, tremor, vomiting, weight loss, anorexia, bacteremia, decreased appetite, erythema of skin, flushing, irritability, pain at injection site, and xeroderma. Other side effects include: increased serum creatinine. See below for a comprehensive list of adverse effects.
For the ConsumerApplies to clofarabine: intravenous solution
Along with its needed effects, clofarabine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking clofarabine:
More common
Less common
Incidence not known
Some side effects of clofarabine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
For Healthcare Professionals
Applies to clofarabine: intravenous solution
GastrointestinalVery common (10% or more): Vomiting (78%), nausea (73%), diarrhea (56%), abdominal pain (35%), gingival or mouth bleeding (17%), mucosal inflammation (16%)
Common (1% to 10%): Upper abdominal pain, oral mucosal petechiae, proctalgia, stomatitis, cecitis, pancreatitis
Postmarketing reports: GI hemorrhage (including fatalities)
OtherVery common (10% or more): Pyrexia (39%), chills (34%), fatigue (34%), pain (15%), edema (12%), asthenia (10%)
HematologicVery common (10% or more): Leukopenia (88%), anemia (83%), lymphopenia (82%), thrombocytopenia (81%), neutropenia (64%), febrile neutropenia (55%), nonfebrile neutropenia (10%)
DermatologicVery common (10% or more): Pruritus (43%), rash (38%), petechiae (26%), palmar-plantar erythrodysesthesia syndrome (16%), erythema (11%)
Common (1% to 10%): Rash pruritic
Postmarketing reports: Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN) (including fatal cases)
Nervous systemVery common (10% or more): Headache (43%), anxiety (21%), lethargy (10%), somnolence (10%)
Common (1% to 10%): Agitation
HepaticVery common (10% or more): SGPT elevated (81%), SGOT elevated (74%), bilirubin elevated (45%)
Common (1% to 10%): Jaundice, hyperbilirubinemia
CardiovascularVery common (10% or more): Tachycardia (35%), hypotension (29%), flushing (19%), hypertension (13%)
Common (1% to 10%): Pericardial effusion
RespiratoryVery common (10% or more): Epistaxis (27%), dyspnea (13%), pleural effusion (12%), pneumonia (10%), respiratory distress (10%), respiratory syncytial virus infection, sinusitis
Common (1% to 10%): Upper respiratory tract infection, tachypnea, pulmonary edema
MusculoskeletalVery common (10% or more): Pain in extremity (34%), myalgia (16%), back pain (12%), bone pain (11%)
Common (1% to 10%): Arthralgia
PsychiatricVery common (10% or more): Irritability (11%)
Common (1% to 10%): Mental status change
GenitourinaryVery common (10% or more): Hematuria (13%)
RenalVery common (10% or more): Creatinine elevated (50%)
OncologicCommon (1% to 10%): Tumor lysis syndrome
HypersensitivityCommon (1% to 10%): Hypersensitivity
ImmunologicVery common (10% or more): Sepsis, including septic shock (17%), catheter related infection (12%), herpes simplex (10%)
Common (1% to 10%): Clostridium colitis, bacteremia, staphylococcal bacteremia, staphylococcal sepsis, candidiasis, cellulitis, herpes zoster, oral candidiasis, bacterial infection, enterococcal bacteremia, escherichia bacteremia, escherichia sepsis, fungal infection, fungal sepsis, gastroenteritis adenovirus, infection, influenza, parainfluenza virus infection, pneumonia fungal, pneumonia primary atypical, staphylococcal infection
MetabolicVery common (10% or more): Anorexia (30%)
Postmarketing reports: Hyponatremia
Medically reviewed by USARx EDITORIAL TEAM Last updated on 1/27/2021.
Source: Drugs.com Clofarabine (www.drugs.com/mtm/clofarabine.html).
December 16, 2020
March 1, 2021
February 15, 2021
March 1, 2021
February 1, 2021
January 31, 2021